Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Shi, Zhengli

Class:Id	Person:9681003
_displayName	Shi, Zhengli
_timestamp	2020-03-31 14:32:32
created	[InstanceEdit:9681042] Jassal, Bijay, 2020-03-31
firstname	Zhengli
initial	Z
surname	Shi
(author)	[LiteratureReference:9681054] Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [LiteratureReference:9683448] Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis [LiteratureReference:9731677] Structure of M^pro from SARS-CoV-2 and discovery of its inhibitors [LiteratureReference:9733490] Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
[Change default viewing format]

No pathways have been reviewed or authored by Shi, Zhengli (9681003)